Vaxcyte Chief Technical Ops Officer Harpreet S. Dhaliwal forfeited 7,651 shares at $60.36 per share on Sep 8. The transaction represented about 10.1% of Dhaliwal’s prior holding, while his resulting position stood at 68,085 shares, giving investors the stated scale of the ownership change.
Key Highlights
- Harpreet S. Dhaliwal owned 68,085 Vaxcyte shares after the transaction.
- The forfeiture represented about 10.1% of Dhaliwal’s prior share holding.
- Vaxcyte Chief Technical Ops Officer Harpreet S. Dhaliwal forfeited 7,651 shares.
- The shares were valued at $60.36 per share, with the transaction recorded on Sep 8, 2026.
Vaxcyte, Inc. (NASDAQ: PCVX) Chief Technical Ops Officer Harpreet S. Dhaliwal forfeited 7,651 shares at $60.36 per share on Sep 8. Dhaliwal is Vaxcyte’s Chief Technical Ops Officer. The transaction record links the forfeiture to 7,651 shares and assigns a value of $60.36 per share. The activity was recorded on Sep 8, 2026.
Resulting Holding Stands at 68,085 Shares
Dhaliwal owned 68,085 Vaxcyte shares after the forfeiture. The transaction represented about 10.1% of his prior share holding. That percentage describes the portion of his earlier position represented by the shares forfeited.
FAQs
Q: How many Vaxcyte shares did Harpreet Dhaliwal forfeit?
A: Harpreet S. Dhaliwal forfeited 7,651 Vaxcyte shares at $60.36 per share on Sep 8, 2026. The forfeiture represented about 10.1% of his prior holding.
Q: What was the impact of the Vaxcyte share transaction?
A: The forfeiture represented about 10.1% of Dhaliwal’s prior share holding. His ownership after the transaction stood at 68,085 Vaxcyte shares.
Q: What does Vaxcyte transaction code F mean?
A: It reports a forfeiture involving 7,651 shares valued at $60.36 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.